Cargando…

Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone

BACKGROUND: Ultrasound (US) has been used to enhance thrombolytic therapy in the treatment of stroke. Considerable attenuation of US intensity is however noted if US is applied over the temporal bone. The aim of this study was therefore to explore possible changes in the effect of thrombolytic drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Härdig, Bjarne Madsen, Carlson, Jonas, Roijer, Anders
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533283/
https://www.ncbi.nlm.nih.gov/pubmed/18727834
http://dx.doi.org/10.1186/1471-2261-8-19
_version_ 1782159021961117696
author Härdig, Bjarne Madsen
Carlson, Jonas
Roijer, Anders
author_facet Härdig, Bjarne Madsen
Carlson, Jonas
Roijer, Anders
author_sort Härdig, Bjarne Madsen
collection PubMed
description BACKGROUND: Ultrasound (US) has been used to enhance thrombolytic therapy in the treatment of stroke. Considerable attenuation of US intensity is however noted if US is applied over the temporal bone. The aim of this study was therefore to explore possible changes in the effect of thrombolytic drugs during low-intensity, high-frequency continuous-wave ultrasound (CW-US) exposure. METHODS: Clots were made from fresh venous blood drawn from healthy volunteers. Each clot was made from 1.4 ml blood and left to coagulate for 1 hour in a plastic test-tube. The thrombolytic drugs used were, 3600 IU streptokinase (SK) or 0.25 U reteplase (r-PA), which were mixed in 160 ml 0.9% NaCl solution. Continuous-wave US exposure was applied at a frequency of 1 MHz and intensities ranging from 0.0125 to 1.2 W/cm(2). For each thrombolytic drug (n = 2, SK and r-PA) and each intensity (n = 9) interventional clots (US-exposed, n = 6) were submerged in thrombolytic solution and exposed to CW-US while control clots (also submerged in thrombolytic solution, n = 6) were left unexposed to US. To evaluate the effect on clot lysis, the haemoglobin (Hb) released from each clot was measured every 20 min for 1 hour (20, 40 and 60 min). The Hb content (mg) released was estimated by spectrophotometry at 540 nm. The difference in effect on clot lysis was expressed as the difference in the amount of Hb released between pairs of US-exposed clots and control clots. Statistical analysis was performed using Wilcoxon's signed rank test. RESULTS: Continuous-wave ultrasound significantly decreased the effects of SK at intensities of 0.9 and 1.2 W/cm(2 )at all times (P < 0.05). Continuous-wave ultrasound significantly increased the effects of r-PA on clot lysis following 20 min exposure at 0.9 W/cm(2 )and at 1.2 W/cm(2), following 40 min exposure at 0.3, 0.6, 0.9 and at 1.2 W/cm(2), and following 60 min of exposure at 0.05 0.3, 0.6, 0.9 and at 1.2 W/cm(2 )(all P < 0.05). CONCLUSION: Increasing intensities of CW-US exposure resulted in increased clot lysis of r-PA-treated blood clots, but decreased clot lysis of SK-treated clots.
format Text
id pubmed-2533283
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25332832008-09-11 Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone Härdig, Bjarne Madsen Carlson, Jonas Roijer, Anders BMC Cardiovasc Disord Research Article BACKGROUND: Ultrasound (US) has been used to enhance thrombolytic therapy in the treatment of stroke. Considerable attenuation of US intensity is however noted if US is applied over the temporal bone. The aim of this study was therefore to explore possible changes in the effect of thrombolytic drugs during low-intensity, high-frequency continuous-wave ultrasound (CW-US) exposure. METHODS: Clots were made from fresh venous blood drawn from healthy volunteers. Each clot was made from 1.4 ml blood and left to coagulate for 1 hour in a plastic test-tube. The thrombolytic drugs used were, 3600 IU streptokinase (SK) or 0.25 U reteplase (r-PA), which were mixed in 160 ml 0.9% NaCl solution. Continuous-wave US exposure was applied at a frequency of 1 MHz and intensities ranging from 0.0125 to 1.2 W/cm(2). For each thrombolytic drug (n = 2, SK and r-PA) and each intensity (n = 9) interventional clots (US-exposed, n = 6) were submerged in thrombolytic solution and exposed to CW-US while control clots (also submerged in thrombolytic solution, n = 6) were left unexposed to US. To evaluate the effect on clot lysis, the haemoglobin (Hb) released from each clot was measured every 20 min for 1 hour (20, 40 and 60 min). The Hb content (mg) released was estimated by spectrophotometry at 540 nm. The difference in effect on clot lysis was expressed as the difference in the amount of Hb released between pairs of US-exposed clots and control clots. Statistical analysis was performed using Wilcoxon's signed rank test. RESULTS: Continuous-wave ultrasound significantly decreased the effects of SK at intensities of 0.9 and 1.2 W/cm(2 )at all times (P < 0.05). Continuous-wave ultrasound significantly increased the effects of r-PA on clot lysis following 20 min exposure at 0.9 W/cm(2 )and at 1.2 W/cm(2), following 40 min exposure at 0.3, 0.6, 0.9 and at 1.2 W/cm(2), and following 60 min of exposure at 0.05 0.3, 0.6, 0.9 and at 1.2 W/cm(2 )(all P < 0.05). CONCLUSION: Increasing intensities of CW-US exposure resulted in increased clot lysis of r-PA-treated blood clots, but decreased clot lysis of SK-treated clots. BioMed Central 2008-08-26 /pmc/articles/PMC2533283/ /pubmed/18727834 http://dx.doi.org/10.1186/1471-2261-8-19 Text en Copyright © 2008 Härdig et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Härdig, Bjarne Madsen
Carlson, Jonas
Roijer, Anders
Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_full Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_fullStr Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_full_unstemmed Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_short Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_sort changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533283/
https://www.ncbi.nlm.nih.gov/pubmed/18727834
http://dx.doi.org/10.1186/1471-2261-8-19
work_keys_str_mv AT hardigbjarnemadsen changesinclotlysislevelsofreteplaseandstreptokinasefollowingcontinuouswaveultrasoundexposureatultrasoundintensitiesfollowingattenuationfromtheskullbone
AT carlsonjonas changesinclotlysislevelsofreteplaseandstreptokinasefollowingcontinuouswaveultrasoundexposureatultrasoundintensitiesfollowingattenuationfromtheskullbone
AT roijeranders changesinclotlysislevelsofreteplaseandstreptokinasefollowingcontinuouswaveultrasoundexposureatultrasoundintensitiesfollowingattenuationfromtheskullbone